biotechnology companies, and private sector innovators who need specialized solutions in the fields of molecular biology, genomics, recombinant biomolecules, immunoassay, lateral flow testing, and bioprocessing, but often face limited local infrastructure, complex procurement procedures, fragmentation of suppliers, and long access cycles. BIOTRANSFER acts as a regional bridge between scientific demand and the mature capabilities of biotechnology. Through its platform model, it connects customers to specialized services, validated technical processes, international suppliers, scientific expertise, and the implementation of local projects. This allows researchers and organizations to move more quickly from concept to experimental validation, prototyping, technology transfer, and deployment. The company's service areas are molecular biology, support for oligonucleotides and plasmids, genomics and sequencing solutions, recombinant proteins, antibodies, synthetic peptides, serological tests, immunoassay components, materials for lateral flow tests, bio-procedural design, laboratory workflow support, technical documentation, and scientific consultancy for applied life sciences projects. BIOTRANSFER aims to reduce operational barriers that hamper the development of biotechnologies in Latin America. These include limited access to specialized suppliers, fragmented procurement of reagents and biomolecules, lack of integrated technical support, delays in the import of scientific materials, lack of local bio-procurement capacity, and the need for scientific guidance specific to the project. By combining technical expertise, coordination of suppliers and local implementation, BIOTRANSFER helps clients to access advanced biotechnology capabilities without having to build all the infrastructure in-house. The company serves a wide range of sectors, including human health, molecular diagnostics, research on infectious diseases, agro-biotechnology, veterinary biotechnology, bio-proteins development, life sciences research, academic innovation and applied biotechnology projects. Its work supports early-stage research, development of tests, demonstration studies, procurement of biomolecules, prototyping and deployment of technologies. The aim of the BIOTRANSFER initiative is to become a leading platform for life sciences in Latin America by helping to bridge the gap in technology access between global biotechnology capabilities and local scientific needs. The long-term vision is to strengthen regional biotechnology ecosystems by providing access to advanced life sciences services and solutions in a faster, more reliable, and more technically informed way.